Surgenex is a biotechnology and manufacturing startup founded in 2015. The company’s slogan "Pioneering The Future Today" reflects its commitment to innovation in the field of human cellular and tissue-based products. Surgenex specializes in delivering products that meet stringent quality and safety standards through a dedicated team of professionals. The company offers a diverse range of capabilities, including a suite of birth tissue allografts, customized demineralized bone matrix implants, allograft solutions for implant and reconstructive dentistry, advanced allograft therapies, acellular dermal matrix, and precision milled structural allografts to support spinal surgery. Although no specific headquarters or recent investment information is available, Surgenex positions itself as an industry leader in contract research and manufacturing, emphasizing exceptional quality, best-in-class customer service, and on-time delivery.
There is no investment information
No recent news or press coverage available for Surgenex.